Check our Open Access Repository.
2022
146 publication(s):
Note: when necessary, only the first 5 authors are displayed.
Articles
- 71 -
-
Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development
- Anais M Quemener, Maria Laura Centomo, Scott L Sax, Riccardo Panella
- Molecules, 2022, 27 (2),
- DOI : https://doi.org/10.3390/molecules27020536
- Pubmed : 35056851
-
- 72 -
-
Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16
- Anais M. Quemener, Laura Bachelot, Marc Aubry, Stéphane Avner, Delphine Leclerc et al.
- Life Science Alliance, 2022, 5 (12), pp.e202201643.
- DOI : https://doi.org/10.26508/lsa.202201643
- Pubmed : 36202613
-
-
- 73 -
-
Antisense oligonucleotide: A promising therapeutic option to beat COVID-19
- Anais M. Quemener, Marie-Dominique Galibert
- Wiley Interdisciplinary Reviews-RNA, 2022, 13 (4),
- DOI : https://doi.org/10.1002/wrna.1703
- Pubmed : 34842345
-
-
- 74 -
-
À la (re)découverte du rôle majeur des cellules souches hématopoïétiques dans l’immunité
The (re)discovery of the major role of haematopoietic stem cells in immunity
- Veronique Maguer-Satta, Frédéric Mazurier
- À la (re)découverte du rôle majeur des cellules souches hématopoïétiques dans l’immunité. Hématologie, 2022, 28 (1), pp.54-54.
- DOI : https://doi.org/10.1684/hma.2021.1714
-
-
- 75 -
-
Substrate recognition and cryo-EM structure of the ribosome-bound TAC toxin of Mycobacterium tuberculosis
- Moise Mansour, Emmanuel Giudice, Xibing Xu, Hatice Akarsu, Patricia Bordes et al.
- Nature Communications, 2022, 13 (1), pp.2641.
- DOI : https://doi.org/10.1038/s41467-022-30373-w
- Pubmed : 35552387
-
-
- 76 -
-
Prenatal phenotype of 22q11 micro-duplications: A systematic review and report on 12 new cases
- Laura Mary, Alinoe Lavillaureix, Adélie Perrot, Philippe Loget, Erika Launay et al.
- European Journal of Medical Genetics, 2022, 65 (2), pp.104422.
- DOI : https://doi.org/10.1016/j.ejmg.2022.104422
- Pubmed : 35026468
-
-
- 77 -
-
Syndrome de Down (trisomie 21), un paradigme des hémopathies malignes de l’enfant
Down syndrome (trisomy 21), a paradigm of childhood haematological malignancies
- Frédéric Mazurier, Thomas Mercher
- Syndrome de Down (trisomie 21), un paradigme des hémopathies malignes de l’enfant. Hématologie, 2022, 28 (1), pp.36-37.
- DOI : https://doi.org/10.1684/hma.2022.1727
-
-
- 78 -
-
Towards a reproducible interactome: semantic-based detection of redundancies to unify protein-protein interaction databases
- Marc Melkonian, Camille Juigné, Olivier Dameron, Gwenaël Rabut, Emmanuelle Becker et al.
- Bioinformatics, 2022, Proceedings, 38 (6), pp.1-7.
- DOI : https://doi.org/10.1093/bioinformatics/btac013
- Pubmed : 35015827
-
-
- 79 -
-
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study
- Mohamad Mohty, Didier Blaise, Régis Peffault de Latour, Myriam Labopin, Jean Henri Bourhis et al.
- Bone Marrow Transplantation, 2022,
- DOI : https://doi.org/10.1038/s41409-022-01900-6
- Pubmed : 36564486
-
-
- 80 -
-
Identification of Bipotential Blood Cell/Nephrocyte Progenitors in Drosophila: Another Route for Generating Blood Progenitors
- Ismaël Morin-Poulard, Manon Destalminil-Letourneau, Laetitia Bataillé, Jean-Louis Frendo, Gaëlle Lebreton et al.
- Frontiers in Cell and Developmental Biology, 2022, 10, pp.834720.
- DOI : https://doi.org/10.3389/fcell.2022.834720
- Pubmed : 35237606
-
-